Doctokem Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -0.03%
- Profit Growth -25.92%
- Ebitda -531.75%
- Net Worth
- Total Assets 29.50%
About Doctokem Pharma
Doctokem Pharma Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 August 2010 and has a history of 14 years and six months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swapnil Chaudhari and Pravin Andhale serve as directors at the Company.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397MH2010PTC206182
- Company No.
206182
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2010
- Date of AGM
22 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Doctokem Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapnil Chaudhari  | Director | 02-Aug-2010 | Current |
| Pravin Andhale | Additional Director | 19-Apr-2018 | Current |
Financial Performance of Doctokem Pharma.
Doctokem Pharma Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 0.03% decrease. The company also saw a substantial fall in profitability, with a 25.92% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctokem Pharma?
In 2017, Doctokem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Doctokem Pharma?
Unlock and access historical data on people associated with Doctokem Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctokem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctokem Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
